Evidence map›Paper›PMID 39775198›Full record

ArticlePloS one2025

Innovameter: Agent-based modeling of innovation determinants in American and European countries.

Arles Rodríguez, Mercedes Gaitán-Angulo, Melva Inés Gómez-Caicedo, Paula Robayo-Acuña, Iván Ricardo Ruíz-Castro

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arles RodríguezDepartamento de Matemáticas, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0003-4910-6773
Mercedes Gaitán-AnguloEscuela de Negocios, Fundación Universitaria Konrad Lorenz, Bogotá, Colombia.
Melva Inés Gómez-CaicedoFacultad de Economía y Ciencias Contables, Fundación Universitaria Los Libertadores, Bogotá, Colombia.ORCID 0000-0002-9020-0051
Paula Robayo-AcuñaEscuela de Negocios, Fundación Universitaria Konrad Lorenz, Bogotá, Colombia.ORCID 0000-0001-5758-0235
Iván Ricardo Ruíz-CastroEscuela de Posgrados, Fundación Universitaria Konrad Lorenz, Bogotá, Colombia.ORCID 0009-0003-6141-9163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article discusses the dynamics of innovation in America and Europe, focusing on variables such as access to technology, education, and life expectancy. To do this, the article proposes an agent-based model called the Innovameter. The dependent variable is the Global Innovation Index. The paper focuses on data analysis through correlation analysis and multiple hierarchical regressions to determine the contribution of specific variables related to the pillars of the Global Innovation Index and indicators of the Human Development Index. After analyzing the data, an agent-based model was built to parameterize these main variables by defining two levels of abstraction: at the global level, there is the country, where birth rates, life expectancy, ICT use, and research and development are defined. At the local level, we define the individuals who have an age, years of schooling, and income. A series of experiments were conducted by selecting data from 30 countries. From the results of the experiments, a nonparametric correlation analysis was performed, and correlation indices were obtained indicating a relationship between the predicted outcomes and the outcomes in the global index. The proposed model aims to provide suggestions on how the different variables can become the norm in most of the countries studied.

Indexed as

InventionsEuropeHumansLife ExpectancyModels, Theoretical

Identifiers

PMID39775198
PMCPMC11706465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.